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Case Report - A forgotten Dermatological Disease
A 42 year old woman was admitted to hospital with a one 
month history of  progressive forgetfulness, irritability and 
confusion. There was no history of  tremor or confabulation. 
Reportedly, she also had fever two weeks prior to admission. 
There was no history of  headache, neck-ache or neck stiffness. 
Further inquiry revealed she had developed rash around her 
neck and in the distal parts of  all four limbs a month prior to 
the onset of  the altered mental status. There was no history 
of  rash involving the mucosae or of  having taken any drugs 
in the period preceding the rash. The guardians also reported 
that the patient had had diarrhea which was watery and had 
lasted a week prior to admission. There was no history of  
vomiting.
She had no history of  tuberculosis, diabetes or hypertension. 
She had been staying in Lilongwe until the illness. She is 
married with seven children. One child died of  an unknown 
cause. There was no other family member who had been 
reported with a similar illness. Her husband was employed 
and worked as a gardener. To generate extra income for 
her family, she has been distilling kachasu (local spirits) 
for commercial purposes since 1999. She had a history of  
alcohol consumption (4 units per day) since 2005.
Reportedly, she was intoxicated most days of  the week. She 
had a 1 pack-year history of  smoking.
Her meals mainly consisted of  nsima and vegetables. 
However, she would often neglect herself  and fail to eat 
when intoxicated from alcohol.
On examination, she was irritable and confused. Her 
Glasgow Coma Score was 14. She had no neck stiffness or 
tenderness. There was no flapping tremor or stigmata of  
chronic liver disease.
Her blood pressure was 120/60 mmHg, pulse rate 96/
minute, respiratory rate 20/minute and temperature 37.90C. 
There was a hyperpigmented well-marginated rash around 
her neck involving most of  C3 and C4 dermatomes (figure 
1 and 2). She had similar rashes in other sun exposed areas 
of  the body.
These were more pronounced in the dorsal aspects of  the 
hands and feet (figure 3 and 4).
There was a vesicular rash on her upper lip which had begun 
crusting (figure 1).
Her cardiovascular, respiratory, abdominal examinations 
were normal. Her initial investigation results on admission 
revealed that she was HIV negative. Her full blood count was 
as follows: WBC 3.6 x 109/L, Hb
12.2g/dL MCV 96 fL, MCH 32.3 pg, Platelets 223 x 109/L. 
The cerebrospinal fluid (CSF) analysis was normal. There 
was no growth from the CSF and blood after 7 days. She had 
tested VDRL negative. The renal function results showed 
creatinine of  0.59mg/dl, BUN of  6mg/dl, sodium of  141 
mmol/L and calcium of  2.3mmol/L (corrected for albumin 
which was normal)
Question
What is the diagnosis?
What is the name of the hyperpigmentation around 
the neck?
Discussion
Pellagra was first described by a Spanish physician Don 
Gaspar Casal in 1735. He called the disease “mal de la rosa,” 
because all the affected patients had the typical reddish and 
glossy rash on the dorsum of  the hands and feet. The rash 
around the neck carries his name: Casal’s collar or necklace 
1, 2. Casal noted the disease among the poor of  Spain. The 
disease is characterized by the four D’s: Dermatitis, Diarrhea, 
and Dementia and in some cases Death. The dermatitis of  
pellagra is characteristically present in sun exposed area. 
Dementia is evidenced by the progressive forgetfulness.3  
Pellagra results from a systemic cellular deficiency of  Niacin 
(Vitamin B3). Niacin can be directly obtained from diet or 
synthesized from an essential amino acid tryptophan. It is 
estimated that 60mg of  tryptophan will produce 1mg of  
niacin in the presence of  vitamin B2 and B6. 3 The daily 
allowance recommended for niacin is 15- 20mg. 
Primary pellagra results when the diet is deficient in niacin or 
tryptophan. The niacin is converted into nicotinamide in the 
body which is a component of  co-enzyme 1 and coenzyme
2. These compounds are involved in glycolysis, protein 
and amino acid metabolism, pyruvate metabolism, pentose 
biosynthesis, generation of  ATP bonds, glycerol metabolism 
and free fatty acid metabolism. Secondary pellagra results 
when there is enough dietary niacin but disease processes 
interfere with its intake, absorption or metabolism. The 
secondary causes include (but are not limited to) chronic 
alcoholism and a variety of  chronic bowel disorders. 
Sporadic cases among alcoholics have been reported.4, 5 Our 
patient had a considerable history of  alcohol consumption 
which makes it very likely to have been the cause of  the 
pellagra. Primary pellagra was unlikely in view of  the fact 
that it was absent in the other members of  the family who 
had been taking the same diet. Other causes of  secondary 
pellagra which were very unlikely in our patient but that 
need consideration in any patient with pellagra include 
prolonged diarrhoea, anorexia nervosa, tuberculosis of  
the gastrointestinal system, chronic colitis, regional ileitis, 
severe ulcerative colitis, hepatic cirrhosis, carcinoid tumour, 
Hartnup’s syndrome and medication: 5-fluorouracil, 
pyrazinamide, 6-mercaptopurine, isoniazid, phenobarbital 
and chloramphenicol.6,7,8,9 Investigations in any patient who 
presents with confusion should include an HIV test and 
cerebrospinal fluid (CSF) analysis (unless there is a contra-
indication). Our patient tested negative for HIV antibodies. 
Her CSF analysis was normal. Metabolic causes of  confusion 
need be considered as well. These include hyponatraemia, 
hypernatraemia or hypercalcaemia. In our patient, the 
electrolyte results were normal. In view of  the reported fever 
prior to admission, her blood was taken for culture and there 
was no growth. The reported fever was thought to be most 
likely due to herpes simplex reactivation as she had herpetic 
vesicular rash on her upper lips that had already started 
crusting when she presented.
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Clinical Progress
The patient was treated with vitamin B tablets compound, 
strong. The adult dose for acute pellagra is nicotinamide 
100mg orally every 6 hours for several days or until 
resolution of  major features.3   Each Vitamin B tablet 
compound (‘strong’) contains 20mg of  nicotinamde. It also 
contains pyridoxine and riboflavin which are needed in the 
synthesis of  niacin from dietary tryptophan. Therefore the 
concomitant administration of  these is desirable. There was 
gradual resolution of  the confusion. She had no diarrhoea 
during the admission. Nine days later, she was discharged.
The patient together with her guardians was counselled on 
stopping alcohol, ensuring a diet rich in protein and niacin, 
and avoiding sun exposure. Food sources of  niacin and/or 
tryptophan include yeast, eggs, bran, peanuts, meat, poultry, 
fish, legumes and whole grain cereals. Maize contains 
considerable amount of  niacin but it is in bound form 
and therefore not readily bioavailable. She was advised to 
continue to take  vitamin B compound, until the resolution 
of  the skin lesions. The nicotinamide was stepped down to 
50mg every 8 – 12 hours on discharge.1 Other supportive 
management included emollients for the skin lesions.
The prognosis of  pellagra is excellent when treated 
appropriately.3 On the other hand, untreated pellagra will 
slowly progress, and lead to death within 4 -5 years. Our 
patient was scheduled for a follow up visit after one month, 
but she did not attend.  
Conclusion
This is a classical case of  pellagra. It is likely that there are 
many patients with pellagra who are not being diagnosed. 
During the time in which we have been writing up this 
case, three other cases have been diagnosed in this hospital. 
This case report serves to remind us to think of  pellagra in 
patients with any of  the component symptoms - dermatitis, 
diarrhoea or dementia, and especially in patients with all 
three of  these. . It also illustrates the importance of  taking 
a thorough social and dietary history, as these may give the 
clues to the diagnosis.
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